Holen Sie sich die Stockscreener-App
17.05
0.99%
-0.125
Handel nachbörslich:
17.06
0.005
+0.03%
First Tracks Biotherapeutics Inc Aktie (TRAX) Neueste Nachrichten
First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences - Sahm
Zumiez Inc. to Report Fiscal 2026 First Quarter Results - The Manila Times
Autoimmune drug biotech First Tracks to meet investors at Jefferies, Leerink - Stock Titan
First Tracks Biotherapeutics (TRAX) Stock Forecast and Price Target 2026 $TRAX - MarketBeat
TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC
First Tracks Biotherapeutics, Inc.Ordinary Shares (NQ: TRAX - FinancialContent
AnaptysBio (ANAB) Valuation After Spin Off And Shift To Royalty Focused Model - Sahm
First Tracks Biotherapeutics (NASDAQ: TRAX) registers 10.5M resale shares; issuer gets no proceeds - Stock Titan
Emily Bodnar Reiterates Buy on AnaptysBio, Keeps $30 Price Target on ANB033 Progress and Solid Cash Runway - TipRanks
TRAX SEC FilingsFirst Tracks Biotherapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Form 424B3 First Tracks Biotherapeu - StreetInsider
First Tracks Biotherapeutics (NASDAQ: TRAX) registers 10.5M resale shares - Stock Titan
First Tracks Biotherapeutics 1Q 2026: Net loss $(50.5M), Revenue $0— 10-Q Summary - TradingView
[Form 4] First Tracks Biotherapeutics, Inc. Insider Trading Activity - Stock Titan
First Tracks Biotherapeutics (NASDAQ: TRAX) details Q1 loss and major post spin-off cash raises - Stock Titan
First Tracks Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update - The Manila Times
[8-K] First Tracks Biotherapeutics, Inc. Reports Material Event - Stock Titan
Director at First Tracks Bio (NASDAQ: TRAX) receives new equity awards - Stock Titan
Director Magda Marquet granted options and RSUs at First Tracks (TRAX) - Stock Titan
Director at First Tracks Biotherapeutics (TRAX) granted options and RSUs - Stock Titan
Director John A. Orwin receives new equity awards at First Tracks Biotherapeutics (TRAX) - Stock Titan
First Tracks (TRAX) awards director 42,000 options and 15,000 RSUs - Stock Titan
Executive equity awards at First Tracks Biotherapeutics (TRAX) detailed - Stock Titan
First Tracks (TRAX) CEO receives new stock options and RSU awards - Stock Titan
First Tracks Biotherapeutics (TRAX) CFO receives new option and RSU awards - Stock Titan
First Tracks Biotherapeutics, Inc. (TRAX) Cash From Financing (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Dividend (TTM) - Zacks Investment Research
This First Tracks Biotherapeutics analyst begins coverage on a bullish note; here are top 4 initiations for Monday - MSN
[EFFECT] First Tracks Biotherapeutics, Inc. SEC Filing - Stock Titan
Is AnaptysBio (ANAB) 51.9% Undervalued After Q1 2026 EPS/Revenue - GuruFocus
TRAX Should I Buy - Intellectia AI
AnaptysBio (NASDAQ: ANAB) shifts to royalty focus after Q1 2026 loss - Stock Titan
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update - Yahoo Finance
First Tracks Biotherapeutics, Inc. (TRAX) - Zacks Investment Research
Two new option listings and one option delisting on May 11th - TipRanks
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
First Tracks Biotherapeutics, Inc. (TRAX) Cash From Operations (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Net Income (TTM) - Zacks Investment Research
TRAX: First Tracks Biotherapeutics, Inc.Interactive Chart - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Eps Diluted (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Ps Ratio (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Debt Equity Ratio (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Return On Equity (TTM) - Zacks Investment Research
First Tracks Biotherapeutics Stock Slides After Investors Move to Sell 10 Million Shares - Moomoo
Stocks to Watch: Kestrel Group, First Tracks Biotherapeutics, Inhibrx Biosciences - Moomoo
TRAX Insider Trading (First Tracks Biotherapeutics Inc stock) - StockInvest.us
First Tracks Biotherapeutics Inc Stock Data and SignalsTRAX - StockInvest.us
According to a document submitted to the U.S. Securities and Exchange Commission, existing selling shareholders of First Tracks Biotherapeutics Inc may sell up to 10.5 million shares of the company’s common stock. - Bitget
First Tracks Biotherapeuticsselling stockholders may sell up to 10.5 shares of common stockSEC filing - marketscreener.com
First Tracks Biotherapeutics, Inc. (TRAX) Dividend Yield (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Return On Assets (TTM) - Zacks Investment Research
TRAX Technical Analysis & Stock Price Forecast - Intellectia AI
First Tracks Biotherapeutics, Inc. (TRAX) Price Book Value - Zacks Investment Research
AnaptysBio rises after completing First Tracks spinoff - msn.com
First Tracks (TRAX) Stock Analysis Report | Financials & Insights - Benzinga
TRAX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
TRAX News & Events - Intellectia AI
TRAX Forecast — Price Prediction for 2026. Should I Buy TRAX? - Intellectia AI
TRAX PE Ratio & Valuation, Is TRAX Overvalued - Intellectia AI
1.49%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):